COMMUNIQUÉ DE PRESSE
News
-
Altareit: Altarea press release regarding the Primonial matter
-
Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
-
Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
-
Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
-
KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires
-
Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
-
Datametrex Announces Transition to Semi-Annual Financial Reporting
-
AI/ML Innovations Inc. Closes First Tranche of Private Placement
-
Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
-
Announces Private Placement of Convertible Promissory Notes
-
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
-
AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
-
MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
-
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
-
MHM Corporate: reduces the nominal value of its shares to €0.011